Chinese Journal of Tissue Engineering Research ›› 2012, Vol. 16 ›› Issue (31): 5881-5885.doi: 10.3969/j.issn. 2095-4344.2012.31. 036

Previous Articles     Next Articles

Hepatitis B recurrence and secondary tuberculosis dissemination after liver transplantation in one case

Li Jun, Chen Hong, Fan Tie-yan, Wang X   

  1. Institute of Transplantation, General Hospital of Armed Police Forces, Beijing 100030, China
  • Received:2011-12-03 Revised:2012-01-19 Online:2012-07-29 Published:2012-07-29
  • Contact: Chen Hong, Doctor, Chief physician, Master’s supervisor, Associate director, Institute of Transplantation, General Hospital of Armed Police Forces, Beijing 100030, China ch61520@163.com
  • About author:Li Jun★, Studying for master’s degree, Institute of Transplantation, General Hospital of Armed Police Forces, Beijing 100030, China lijun860219AA@163.com

Abstract:

BACKGROUND: The dissemination of tuberculosis based on hepatic failure because of hepatitis B recurrence after liver transplantation progresses rapidly and there is a contradictory on its treatment.
OBJECTIVE: To summarize the diagnosis, treatment and prognosis of one patient with hepatic failure caused by hepatitis B recurrence after liver transplantation and secondary tuberculosis dissemination.
METHODS: We collected the clinical data of one patient with hepatic failure caused by hepatitis B recurrence and secondary tuberculosis dissemination after liver transplantation in General Hospital of Chinese People’s Armed Police Forces. A retrospectively analysis of the cause, diagnosis, therapeutic method and prognosis of the patients with hepatitis B recurrence or tuberculosis dissemination after liver transplantation reported at home and abroad were preformed.
RESULTS AND CONCLUSION: The treatment for tuberculosis was not completed when hepatitis B recurrent after liver transplantation. Although we tried to finish the treatment for tuberculosis as well as curing hepatitis B, the patient still died. The result shows that the dissemination of tuberculosis based on hepatic failure because of hepatitis B recurrence after liver transplantation progresses rapidly and the prognosis is poor. We should find a balance point between them on the treatment, and stop using immunosuppressive agent necessarily.

CLC Number: